Chimeric melanocortin MC1 and MC3 receptors: Identification of domains participating in binding of melanocyte-stimulating hormone peptides

Molecular Pharmacology

Volumn 54, Issue 1, 1998, Pages 154-161

  Schiöth, Helgi B ^a   Yook, Philip ^a   Muceniece, Ruta ^b   Wikberg, Jarl E S ^a,c   Szardenings, Michael ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; ALPHA INTERMEDIN DERIVATIVE; CHIMERIC PROTEIN; INTERMEDIN; INTERMEDIN DERIVATIVE; MELANOCORTIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR BINDING;

EID: 0344330997     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.1.154     Document Type: Article

References (46)

1. Adan RAH, Oosterom J, Ludviksdottir G, Brakkee JH, Burbach JPH, and Gispen WH (1994) Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors. Eur J Pharmacol 269:331-337.
2. Baldwin JM (1993) The probable arrangement of the helices in G protein-coupled receptors. EMBO J 12:1693-1703.
3. Cammas FM, Kapas S, Barker S, and Clark AJL (1995) Cloning, characterization and expression of a functional mouse ACTH receptor. Biochem Biophys Res Commun 212:912-918.
4. Chhajlani V (1996) Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochem Mol Biol Int 38:73-80.
5. Chhajlani V, Muceniece R, and Wikberg JES (1993) Molecular cloning of a novel human melanocortin receptor. Biochem Biophys Res Commun 195:866-873.
6. Chhajlani V and Wikberg JES (1992) Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 309:417-420.
7. Chhajlani V, Xu X, Blauw J, and Sudarshi S (1996) Identification of ligand binding residues in extracellular loops of the melanocortin 1 receptor. Biochem Biophys Res Commun 219:521-525.
8. Eberle AN (1988) The Melanotropins: Chemistry, Physiology and Mechanisms of Action. Karger, Basel, Switzerland.
9. Fan W, Boston BA, Kesterson RA, Hruby VJ, and Cone RD (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature (Lond) 385:165-168.
10. Fathi Z, Iben LG, and Parker EM (1995) Cloning, expression and tissue distribution of a fifth melanocortin receptor subtype. Neurochem Res 20:107-113.
11. 7]-alpha-MSH at the melanocortin-1 receptor. Biochem Biophys Res Commun 202:1266-1271.
12. Frielle T, Daniel KW, Caron MG, and Lefkowitz RJ (1988) Structural basis of beta-adrenergic receptor subtype specificity studied with chimeric beta 1/beta 2-adrenergic receptors. Proc Natl Acad Sci USA 85:9494-9498.
13. Gantz I, Konda Y, Tashiro T, Shimoto Y, Miwa H, Munzert G, Watson SJ, Del Valle J, and Yamada T (1993a) Molecular cloning of a novel melanocortin receptor. J Biol Chem 268:8246-8250.
14. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson SJ, DelValle J, and Yamada T (1993b) Molecular cloning, expression and gene localization of a fourth melanocortin receptor. J Biol Chem 268:15174-15179.
15. Haskell-Luevano C, Sawyer TK, Trumpp-Kallmayer S, Bikker JA, Humblet C, Gantz I, and Hruby VJ (1996) Three dimensional models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists. Drug Des Discovery 14:197-211.
16. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J Med Chem 38:3454-3461.
17. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, and Lee F (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141.
18. Jung V, Pestka SB, and Pestka S (1993) Cloning of polymerase chain reaction-generated DNA containing terminal restriction endonuclease recognition sites. Methods Enzymol 218:357-362.
19. 10]melanotropin analogues. J Med Chem 28:125-129.
20. Kobilka BK, Kobilka TS, Daniel K, Regan JW, Caron MG, and Lefkowitz RJ (1988) Chimeric alpha2-, beta2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science (Washington DC) 240:1310-1316.
21. Koppula SV, Robbins LS, Lu D, Baack E, White CR Jr, Swansson NA, and Cone RD (1997) Identification of common polymorphisms in the coding sequence of the human MSH receptor (MCIR) with possible biological effects. Hum Mutat 9:30-36.
22. Labbé O, Desarnaud F, Eggerickx DG, Vassart G, and Parmentier M (1994) Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry 33:4543-4549.
23. Landt O, Grunert H-P, and Hahn U (1990) A general method for rapid site-directed mutagenesis using the polymerase chain reaction. Gene 96:125-128.
24. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkinsson WO, and Cone RD (1994) Agouti protein is an antagonist of the melanocyte-stimulating hormone receptor. Nature (Lond) 371:799-802.
25. Marklund L, Johanssson-Möller M, Sandberg K, and Andersson L (1996) A missense mutation in the gene for melanocyte-stimulating hormone receptor (MC1R) is associated with the chestnut coat color in horses. Mamm Genome 7:895-899.
26. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, and Cone RD (1994) Localization of the melanocortin-4 receptor (MC4-R) in endocrine and autonomie control circuits in the brain. Mol Endocrinol 8:1298-1308.
27. Mountjoy KG, Robbins LS, Mortrud MT, and Cone RD (1992) The cloning of a family of genes that encode the melanocortin receptors. Science (Washington DC) 257:1248-1251.
28. Nordstedt C and Fredholm BB (1990) A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. Anal Chem 189:231-234.
29. O'Donahue TL and Dorsa DM (1982) The opiomelanotropinergic neuronal and endocrine systems. Peptides 3:353-395.
30. Prusis P, Frändberg P-A, Muceniece R, Kalvinsh I, and Wikberg JES (1995) A three dimensional model for the interaction of MSH with the melanocortin-1 receptor. Biochem Biophys Res Commun 210:205-210.
31. Robbins LS, Nadeau JH, Johnson KR, Kelly MA, Roselli-Rehfuss L, Baack E, Mountjoy KG, and Cone RD (1993) Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72:827-834.
32. Roselli-Rehfuss L, Mountjoy KG, Robbins LS, Mortrud MT, Low MJ, Tatro JB, Entwistle ML, Simerly RB, and Cone RD (1993) Identification of a receptor for g melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 90:8856-8860.
33. 10]-α-melanocyte stimulating hormone: a cyclic α-melanotropin exhibiting superagonist biological activity. Proc Natl Acad Sci USA 79:1751-1755.
34. 7]α-melanocyte stimulating hormone. A highly potent α-melanotropin with ultralong biological activity. Proc Natl Acad Sci USA 77:5754-5758.
35. Schiöth HB, Chhajlani V, Muceniece R, Klusa V, and Wikberg JES (1996a) Major pharmacological distinction of the ACTH receptor from the other melanocortic receptors. Life Sci 59:797-801.
36. Schiöth HB, Muceniece R, Prusis P, Szardenings M, Lindeberg G, Sharma SD, Hruby VJ, and Wikberg JES (1997a) Characterisation of D117A and H260A mutations in the melanocortin 1 receptor. Mol Cell Endocr 126:213-219.
37. Schiöth HB, Muceniece R, Szardenings M, Prusis P, and Wikberg JES (1996b) Evidence indicating that the TM4, EL2 and TM5 of the melanocortin 3 receptor do not participate in ligand binding. Biochem Biophys Res Commun 229:687-692.
38. Schiöth HB, Muceniece R, and Wikberg JES (1996c) Characterisation of melanocortin 4 receptor by radioligand binding analysis. Pharmacol Toxicol 79:161-165.
39. Schiöth HB, Muceniece R, Wikberg JES, and Chhajlani V (1995) Characterisation of melanocortin receptor subtypes by radioligand binding analysis. Eur J Pharmacol 288:311-317.
40. Schiöth HB, Muceniece R, Wikberg JES, and Szardenings M (1996d) Alternative translation initiation codon for the human melanocortin MC3 receptor does not affect the ligand binding. Eur J Pharmacol 314:381-384.
41. Schiöth HB, Petersson S, Muceniece R, Szardenings M, and Wikberg JES (1997b) Deletions of the N-terminal regions of the human melanocortin receptors. FEBS Lett 410:223-228.
42. Shire D, Calandra B, Delpech M, Dumont X, Kagdad M, Le Fur G, Cuput D, and Ferrara P (1996) Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A. J Biol Chem 271:6941-6946.
43. Valverde P, Healy E, Jacksson I, Rees JL, and Thody AJ (1995) Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 11:328-330.
44. Våge DI, Lu D, Klungland H, Lien S, Adalsteinsson S, and Cone RD (1997) A non-epistatic interaction of agouti and extension in the fox, Vulpes vulpes. Nat Genet 15:311-315.
45. Wang WW, Shahrestanifar M, Jin J, and Howells RD (1995) Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. Proc Natl Acad Sci USA 92:12436-12440.
46. Xu X, Thörnwall M, Lundin L-G, and Chhajlani V (1996) Val92Met variant of the melanocyte stimulating hormone receptor gene. Nat Genet 14:364.